SHELTON CAPITAL MANAGEMENT - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$224,094
-11.8%
5,5250.0%0.02%
+155.6%
Q1 2022$254,000
-30.6%
5,5250.0%0.01%
-30.8%
Q4 2021$366,000
+1.4%
5,525
-4.4%
0.01%
-7.1%
Q3 2021$361,000
-24.5%
5,7770.0%0.01%
-22.2%
Q2 2021$478,000
+24.8%
5,7770.0%0.02%
+38.5%
Q1 2021$383,000
-13.5%
5,7770.0%0.01%
-35.0%
Q4 2020$443,000
+70.4%
5,777
-4.2%
0.02%
+81.8%
Q3 2020$260,0000.0%6,0310.0%0.01%
-21.4%
Q2 2020$260,0006,0310.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders